Evidence map›Paper›PMID 30154211›Full record

ArticleJournal of cell science2018

Neurodegeneration and locomotor dysfunction in

Patrick C Cunningham, Katherine Waldeck, Barry Ganetzky, Daniel T Babcock

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Frontiers in pharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. International journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. 3-Hydroxykynurenine in Regulation ofFrontiers in physiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Patrick C CunninghamDepartment of Biological Sciences, Lehigh University, Bethlehem, PA 18015, USA.
Katherine WaldeckLaboratory of Genetics, University of Wisconsin-Madison, Madison, WI 53706, USA.
Barry GanetzkyLaboratory of Genetics, University of Wisconsin-Madison, Madison, WI 53706, USA.
Daniel T BabcockDepartment of Biological Sciences, Lehigh University, Bethlehem, PA 18015, USA dab416@lehigh.edu.ORCID 0000-0002-8102-9133
Lehigh University · USUniversity of Wisconsin–Madison · US

Funding

Neurogenetics of TS-Paralytic Mutants in DrosophilaR01NS015390 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI GANETZKY, BARRY S · 1985 to 2011
$4.5M
NINDS NIH HHS R01 NS015390
6 · The paper itself

Abstract

Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons, resulting in progressive locomotor dysfunction. Identification of genes required for the maintenance of these neurons should help to identify potential therapeutic targets. However, little is known regarding the factors that render dopaminergic neurons selectively vulnerable to PD. Here, we show that

Indexed as

AnimalsDrosophila melanogasterHumansNeurodegenerative DiseasesParkinson DiseaseDopaminergic neuronKynurenineParkinson's disease

Identifiers

PMID30154211
PMCPMC6176922
OpenAlexW2889353569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.